SCHEMBL6368592

SCHEMBL6368592

C=CCn1c(/C=C/C(C)=O)cc2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HRH1 P35367 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
GLA P06280 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HPGD P15428 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6368595 1.00 KDM4E (0.39) KDM4ETP53ALDH1A1HRH1MEN1
SCHEMBL6369104 0.85 MAPK1 (0.45) KDM4ETP53ALDH1A1LMNAMAPK1
SCHEMBL6364102 0.84 LMNA (0.45) KDM4EALDH1A1MEN1KMT2ANPC1
SCHEMBL6364105 0.84 LMNA (0.45) KDM4EALDH1A1MEN1KMT2ANPC1
SCHEMBL6370665 0.79 PARP1 (0.38) KDM4EALDH1A1HRH1MEN1KMT2A
SCHEMBL6370673 0.79 PARP1 (0.38) KDM4EALDH1A1HRH1MEN1KMT2A
SCHEMBL6364991 0.79 LMNA (0.40) KDM4EALDH1A1HRH1MEN1KMT2A
SCHEMBL6364996 0.79 LMNA (0.40) KDM4EALDH1A1HRH1MEN1KMT2A
SCHEMBL16487399 0.79 CCR2 (0.48) KDM4ETP53ALDH1A1HRH1MEN1
SCHEMBL14387230 0.78 LMNA (0.41) KDM4EALDH1A1HRH1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070591-A1 Indole derivative KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-03-31 US disclosed
EP-1464645-A1 INDOLE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070591-A1 Indole derivative TPH1, IDO1, RBX1 KDM4E 1406/4885TP53 258/4885ALDH1A1 1318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.